Vasospasm in Pediatric Traumatic Brain Injury
PTBI
Measuring Vasospasm, Biomarkers, and Neurocognitive Outcomes in Pediatric Traumatic Brain Injury
1 other identifier
observational
6
1 country
1
Brief Summary
The purpose of this study is to assess for vasospasm using Transcranial Doppler (TCD) and brain injury biomarkers, and evaluate neurocognitive outcome data in pediatric traumatic brain injury (TBI) patients who have experienced a mild to severe head injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 26, 2011
CompletedFirst Posted
Study publicly available on registry
October 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFebruary 2, 2015
January 1, 2015
1.3 years
October 26, 2011
January 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vasospasm detection by Transcranial Doppler Ultrasound
Daily transcranial doppler ultrasound performed in pediatric traumatic head injury patients.
8 days
Secondary Outcomes (1)
Detection of biomarkers in pediatric traumatic brain injury
2 days
Study Arms (1)
Pediatric Traumatic Brain Injury
Children from 5 days to 15 years of age who have been admitted to the hospital with a traumatic brain injury.
Eligibility Criteria
Pediatric patients who have been admitted for a traumatic brain injury to Duke University Hospital.
You may qualify if:
- admission to Duke University Children's Hospital;
- age 5 days to 15 years;
- a diagnosis of a TBI with a GCS 3-15;
- capable of adequate TCD ultrasound examination;
You may not qualify if:
- the presence of previously diagnosed significant neurodevelopmental delay,
- a diagnosis of non-traumatic intracranial hemorrhage and
- parents/legal guardians who do not speak or understand English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karin Reuter-Rice, PhD
Duke University School of Nursing and School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2011
First Posted
October 28, 2011
Study Start
September 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2013
Last Updated
February 2, 2015
Record last verified: 2015-01